Clinical Investigation of the Efficacy and Safety of Anlotinib with Immunotherapy in Advanced Non-Small Cell Lung Cancer as Third-Line Therapy: A Retrospective Study

PURPOSE: This study was designed to assess the clinical efficacy and safety of anlotinib with immunotherapy in advanced non-small cell lung cancer as third-line therapy. PATIENTS AND METHODS: A total of 101 patients with advanced non-small cell lung cancer who were treated with anlotinib combined wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shengjie, Zhang, Wenjie, Chen, Qing, Guo, Qisen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585515/
https://www.ncbi.nlm.nih.gov/pubmed/33116888
http://dx.doi.org/10.2147/CMAR.S280096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585515/
https://www.ncbi.nlm.nih.gov/pubmed/33116888
http://dx.doi.org/10.2147/CMAR.S280096

Ejemplares similares